Study Details

Back
Study ID 506-MA-1001
Study Title A multi-center, randomized, open-label, pilot and exploratory study investigating safety and efficacy in OPTIMIZEd dosing of Advagraf® kidney transplantation in Asia.
Clinicaltrials.gov Identifier NCT02161237
Compound Name FK506E / tacrolimus extended-release
Medical Indication or Disease Prevention of rejection after organ transplant
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 26-Jun-2014
Study Completion Date 22-Dec-2016
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS